HSBC upgrades Moderna to Buy on pipeline potential
HSBC analyst Yifeng Liu upgraded Moderna (MRNA) to Buy from Hold with a price target of $58, down from $82. The recent share ...
Moderna initiated with a Hold at Berenberg
Berenberg analyst Harry Gillis initiated coverage of Moderna (MRNA) with a Hold rating and $42 price target. The firm says mRNA will ...
Moderna’s Strategic Shift and Financial Outlook Leads to Sell Rating and Lowered Price Target
Leerink Partners analyst Mani Foroohar has reiterated their bearish stance on MRNA stock, giving a Sell rating on November 14.Don't Miss our ...
Flexible Solutions Earnings Miss Estimates in Q3, Revenues Up Y/Y
FSI sees higher sales in Q3 on increased customer orders and expects a strong upside in profits for both existing and new ...
Australian Broadcasting Corporation19h
South Australia
Footage of a man being shoved into a wall by a police officer before being dragged through a front yard has been shared on social media, with SA Police confirming a formal complaint has been made ...
Indiatimes5h
Krishna Instt of Medical Sciences - Krishna Institute of Medical Sciences Share Price
Krishna Institute of Medical Sciences Ltd., incorporated in the year 1973, is a Small Cap company (having a market cap of Rs 22,317.75 Crore) operating in Hospitals & Allied Services sector. Krishna ...